Effects of vitamin D on immune disorders with special regard to asthma, COPD and autoimmune diseases: a short review

被引:0
作者
Szekely, Joseph I. [1 ]
Pataki, Agnes [2 ]
机构
[1] Semmelweis Univ, Sch Med, Inst Human Physiol & Clin Expt Res, H-1094 Budapest, Hungary
[2] Egis Pharmaceut PLC, Mol Pharmacol Lab, H-1165 Budapest, Hungary
关键词
autoimmune disorders; COPD; infectious diseases; Th1; cells; Th2; Th17; Treg cells; vitamin D; REGULATORY T-CELLS; D-RECEPTOR GENE; OBSTRUCTIVE PULMONARY-DISEASE; TOLEROGENIC DENDRITIC CELLS; D-BINDING PROTEIN; 25-HYDROXYVITAMIN D LEVELS; GENOME-WIDE ASSOCIATION; VERSUS-HOST DISEASE; SMOOTH-MUSCLE-CELLS; 1,25-DIHYDROXYVITAMIN D-3;
D O I
10.1586/ERS.12.57
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
This paper reviews the recent data on the role of vitamin D ( VD) in the genesis of various immunological disorders. It inhibits immune reactions in general, but it enhances the transcription of 'endogenous antibiotics' such as cathelicidin and defensins. VD inhibits the genesis of both Th1- and Th2-cell mediated diseases. The pleiotropic character VD-induced effects are due to the altered transcription of hundreds of genes. VD supplementation in most related studies reduced the prevalence of asthma. Th1-dependent autoimmune diseases (e.g., multiple sclerosis, Type 1 diabetes, Crohn's disease, rheumatoid arthritis and so on) are also inhibited by VD due to inhibition of antigen presentation, reduced polarization of Th0 cells to Th1 cells and reduced production of cytokines from the latter cells. VD seems to also be a useful adjunct in the prevention of allograft rejection. Last but not least, VD supplementation may be useful in the prevention or adjunct treatment of chronic obstructive pulmonary disease.
引用
收藏
页码:683 / 704
页数:22
相关论文
共 288 条
  • [1] Unexpected actions of vitamin D: new perspectives on the regulation of innate and adaptive immunity
    Adams, John S.
    Hewison, Martin
    [J]. NATURE CLINICAL PRACTICE ENDOCRINOLOGY & METABOLISM, 2008, 4 (02): : 80 - 90
  • [2] The Current STATus of lymphocyte signaling: new roles for old players
    Adamson, Adewole S.
    Collins, Kalonji
    Laurence, Arian
    O'Shea, John J.
    [J]. CURRENT OPINION IN IMMUNOLOGY, 2009, 21 (02) : 161 - 166
  • [3] Adler HS, 2007, EUR J DERMATOL, V17, P476
  • [4] Intervention in autoimmunity: The potential of vitamin D receptor agonists
    Adorini, L
    [J]. CELLULAR IMMUNOLOGY, 2005, 233 (02) : 115 - 124
  • [5] Prevention of chronic allograft rejection by Vitamin D receptor agonists
    Adorini, L
    Amuchastegui, S
    Daniel, KC
    [J]. IMMUNOLOGY LETTERS, 2005, 100 (01) : 34 - 41
  • [6] Tolerogenic dendritic cells induced by vitamin D receptor ligands enhance regulatory T cells inhibiting autoimmune diabetes
    Adorini, L
    [J]. IMMUNE MECHANISMS AND DISEASE, 2003, 987 : 258 - 261
  • [7] Tolerogenic dendritic cells induced by vitamin D receptor ligands enhance regulatory T cells inhibiting allograft rejection and autoimmune diseases
    Adorini, L
    Penna, G
    Giarratana, N
    Uskokovic, M
    [J]. JOURNAL OF CELLULAR BIOCHEMISTRY, 2003, 88 (02) : 227 - 233
  • [8] Adorini Luciano, 2002, Curr Opin Investig Drugs, V3, P1458
  • [9] Adorini Luciano, 2009, Handb Exp Pharmacol, P251, DOI 10.1007/978-3-540-71029-5_12
  • [10] The interleukin-23 axis in intestinal inflammation
    Ahern, Philip P.
    Izcue, Ana
    Maloy, Kevin J.
    Powrie, Fiona
    [J]. IMMUNOLOGICAL REVIEWS, 2008, 226 : 147 - 159